New perspective on type 2 diabetes, dyslipidemia and non‐alcoholic fatty liver disease
Open Access
- 30 March 2020
- journal article
- editorial
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 11 (3) , 532-534
Abstract
Serum lipid abnormalities (dyslipidemias) are major risk factors for cardiovascular disease in type 2 diabetes. The features of diabetic dyslipidemia are elevated plasma concentrations of triglyceride (TG)‐rich lipoproteins (TRLs), small dense low‐density lipoprotein cholesterol (sdLDL‐C) and decreased plasma high‐density lipoprotein cholesterol (HDL‐C) concentrationKeywords
This publication has 14 references indexed in Scilit:
- Hepatocyte growth factor alleviates hepatic insulin resistance and lipid accumulation in high‐fat diet‐fed miceJournal of Diabetes Investigation, 2018
- Plasma tyrosine and its interaction with low high‐density lipoprotein cholesterol and the risk of type 2 diabetes mellitus in ChineseJournal of Diabetes Investigation, 2018
- Dipeptidyl peptidase 4 inhibitor anagliptin ameliorates hypercholesterolemia in hypercholesterolemic mice through inhibition of intestinal cholesterol transportJournal of Diabetes Investigation, 2018
- Contribution and interaction of the low‐density lipoprotein cholesterol to high‐density lipoprotein cholesterol ratio and triglyceride to diabetes in hypertensive patients: A cross‐sectional studyJournal of Diabetes Investigation, 2018
- Non‐high‐density lipoprotein cholesterol is more informative than traditional cholesterol indices in predicting diabetes risk for women with normal glucose toleranceJournal of Diabetes Investigation, 2018
- Angiopoietin‐like protein 8/betatrophin correlates with hepatocellular lipid content independent of insulin resistance in non‐alcoholic fatty liver disease patientsJournal of Diabetes Investigation, 2017
- Comparison of effects of anagliptin and alogliptin on serum lipid profile in type 2 diabetes mellitus patientsJournal of Diabetes Investigation, 2017
- Association between betatrophin/ANGPTL8 and non-alcoholic fatty liver disease: animal and human studiesScientific Reports, 2016
- TATN-1 Mutations Reveal a Novel Role for Tyrosine as a Metabolic Signal That Influences Developmental Decisions and Longevity in Caenorhabditis elegansPLOS Genetics, 2013
- Activation of the Cholinergic Antiinflammatory Pathway Ameliorates Obesity-Induced Inflammation and Insulin ResistanceEndocrinology, 2011